Important informations

Research at the LDI


To convert the insights gained from research to practical applications, it is crucial for scientists to study and validate their findings in more than just animals. Biobanks house biological samples like blood and tissues that are donated by patients. Cells that come directly from patients provide the most accurate picture of the disease or condition we are fighting against. Here you will find a list of the biobanks that are making patients’ samples accessible to scientists so that they can develop novel ways of preventing, diagnosing, and treating specific diseases.

Biobanks at the Jewish General Hospital/Segal Cancer Centre

BioPortal is a unique research platform at the Jewish General Hospital (JGH)/Lady Davis Institute for Medical Research (LDI) built in partnership with the CERC Chair in Genomic Medicine at McGill University. Its goal is to leverage a bank of biomedical information from thousands of patients to incorporate precision medicine and genomics into clinical decision-making and deliver more effective, precise care to patients. BioPortal currently focuses on improving care for diabetes and will then rapidly expand to other common and rare diseases.

BioPortal is open-access, meaning any group who has REB approval and Data Access Committee endorsement can be given access to the data. Researchers can thus have access to:

  • Large quantity of real-world high-quality data from patients diagnosed with diabetes and related metabolic disorders.
  • Such patients for selected, molecularly enriched early development clinical trials.
  • Biological material from such patients.
  • Data, samples and patients diagnosed with specific rare diseases.
  • Possibility to envision population-based secondary prevention of coronary artery disease.

For more information about how to access the BioPortal data and/or material, please click here.


David Morrison